Murine double minute 2 siRNA and wild-type p53 gene therapy enhances sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro and in vivo | |
Wang, Bo; Gu, Junlian; Tang, Yufeng; Liu, Yanan; Guo, Hua; Wang, Yue; Cai, Lu; Li, Yang | |
刊名 | CANCER LETTERS |
2014 | |
卷号 | 343期号:2 |
关键词 | SKOV3/DDP Drug resistance Cisplatin P53 Si-mdm2 |
ISSN号 | 0304-3835 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3546155 |
专题 | 吉林大学白求恩第一医院 |
推荐引用方式 GB/T 7714 | Wang, Bo,Gu, Junlian,Tang, Yufeng,et al. Murine double minute 2 siRNA and wild-type p53 gene therapy enhances sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro and in vivo[J]. CANCER LETTERS,2014,343(2). |
APA | Wang, Bo.,Gu, Junlian.,Tang, Yufeng.,Liu, Yanan.,Guo, Hua.,...&Li, Yang.(2014).Murine double minute 2 siRNA and wild-type p53 gene therapy enhances sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro and in vivo.CANCER LETTERS,343(2). |
MLA | Wang, Bo,et al."Murine double minute 2 siRNA and wild-type p53 gene therapy enhances sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro and in vivo".CANCER LETTERS 343.2(2014). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论